← All Posts
DEN
Denali Therapeutics Inc.
June 04, 2026
•
Author: Phil Ratcliff
| Item |
Proposal |
Vote |
| 1 |
To elect three directors from the nominees described in this proxy statement as Class III directors to serve for a three-year term. |
|
| 1a |
Jennifer Cook |
✓ For(104.075)
|
| 1b |
David Schenkein, M.D. |
✓ For(104.075)
|
| 1c |
Ryan J. Watts, Ph.D. |
Withhold(104.075)
|
| 2 |
To ratify the selection of Ernst & Young LLP as our independent registered public accounting firm for fiscal year ending December 31, 2023. |
✓ For(104.075)
|
| 3 |
To approve, on an advisory basis, executive compensation. |
✓ For(104.075)
|
This article was written for information purposes only and its content should not be
construed by any consumer and/or prospective client as rebel Financial's solicitation
to affect, or attempt to affect transactions in securities, or the rendering of
personalized investment advice for compensation. No client or prospective client should
assume that any such discussion serves as the receipt of, or a substitute for,
personalized advice from rebel Financial, or from any other investment professional.
See our disclosures page for more information.
rebel Financial